Our Take
The funding drought reflects investor pullback from late-stage InsurTech deals, not a collapse in early-stage AI automation opportunities.
Why it matters
InsurTech startups dependent on large growth rounds face a capital crunch, while AI-focused companies still attract half of all available deals. The shift favors operational efficiency plays over consumer-facing propositions.
Do this week
InsurTech founders: pivot pitch decks to emphasize AI automation and workflow efficiency before Q3 fundraising cycles to align with current investor preferences.
April funding dropped to $119m across 8 deals
Global InsurTech investment fell to approximately $119m in April across eight deals, down 50% from March's $237m (per Fintech Global). This extends a sharp decline from February's $1bn-plus peak and marks the first month this year with no deals exceeding $100m.
The largest transaction came from US-based Counterpart, which raised $50m in Series C funding for its AI-driven underwriting and risk platform. UK telematics provider Zego secured $28m to expand into Japan through a partnership with Sompo Holdings, while Malaysia's PolicyStreet raised $21m for its embedded insurance platform across Asia. These three deals accounted for the majority of April's total capital deployment.
The remaining five transactions focused on early-stage companies building AI automation tools for broker workflows, claims processing, and operational infrastructure. Companies including Cara, RIIG Technology, and Felix raised funding for workflow automation across underwriting, healthcare claims, and regulated industry compliance.
Large rounds disappeared while AI deals dominate
Deals over $100m plummeted 85% in H1 2025, falling to $275m from $1.9bn in H2 2024 (per Fintech Global research). This represents a structural shift away from late-stage growth capital toward smaller, specialized investments.
AI and automation platforms captured half of all April deals, spanning underwriting, claims processing, and back-office operations. Embedded insurance and digital distribution models formed the next largest category, while traditional motor and travel insurance propositions secured limited funding.
Geographically, US companies dominated with five of eight deals, consistent with American firms accounting for 51% of global InsurTech deals in Q1 2026 (company-reported). The UK, Malaysia, and Switzerland each recorded single transactions.
Funding strategy must align with automation focus
InsurTech companies seeking growth capital face a constrained environment for deals above $50m. Investors are prioritizing AI-driven operational efficiency over consumer-facing insurance products or traditional coverage models.
The concentration of capital in workflow automation and embedded insurance reflects investor preference for B2B2B models that integrate with existing infrastructure rather than direct-to-consumer propositions. Early-stage companies building AI tools for claims processing, underwriting automation, or broker workflow optimization continue attracting investment despite the broader funding decline.
Companies dependent on large Series B or C rounds should expect extended fundraising cycles and increased scrutiny of unit economics. The April data suggests successful raises require demonstrable AI capabilities applied to specific insurance operational challenges rather than broad digital transformation narratives.